| EEUU Guide (ATS/IDSA;
2007) [1] |
If no significant risks for DRSP*: Macrolide or
doxycycline
If risks for DRSP*: Antipneumococcal
fluoroquinolone![[Bullet]](noicu_archivos/BULL.GIF)
OR
High-dose amoxicillin (3 gm/day) or high dose
amoxicillin/clavulanate (4 gm/day) plus
macrolide (if amoxicillin is used and there is a concern
for H. influenzae, use macrolide active for
-lactamase
producing strains )
OR
Telithromycin![[Lozenge]](noicu_archivos/LOZF.GIF) |
-lactam
(ceftriaxone, cefotaxime, ampicillin/sulbactam,
ertapenem) plus macrolide (can use
doxycycline if macrolide not tolerated)
OR
Antipneumococcal fluoroquinolone alone |
-lactam
(ceftriaxone, cefotaxime, ampicillin/sulbactam)
plus IV azithromycin or IV
fluoroquinolone![[Bullet]](noicu_archivos/BULL.GIF)
If concern for Pseudomonas (eg, presence of
structural lung disease such as bronchiectasis):
antipseudomonal agent (piperacillin/tazobactam,
imipenem, meropenem, or cefepime) plus
antipseudomonal fluoroquinolone (ciprofloxacin or high
dose levofloxacin);
If concern for MRSA (see text): add vancomycin or
linezolid |
| British Thoracic Society (2004) [2] |
Amoxicillin 500-1000 mg thrice daily;
(Alternative therapy: erythromycin or clarithromycin) |
If admitted for non-clinical reasons or previously
untreated in the community: Amoxicillin (macrolide as
alternative)
If admitted for pneumonia and oral therapy
appropriate: Amoxicillin plus
(erythromycin or clarithromycin); (Alternative therapy:
antipneumococcal fluoroquinolone )
If parenteral therapy appropriate: Ampicillin or
benzylpenicillin plus (erythromycin or
clarithromycin); (Alternative therapy: IV levofloxacin,
note IV moxifloxacin not available in UK) |
Co-amoxiclav or 2nd/3rd generation
cephalosporin plus (IV erythromycin or
clarithromycin, +/- rifampin); (IV levofloxacin
plus IV benzylpenicillin as
alternative) |